Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Other Non-Current Liabilities (2016 - 2026)

Insmed's Other Non-Current Liabilities history spans 16 years, with the latest figure at $5.7 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 96.96% to $5.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Mar 2026, down 96.96% year-over-year, with the annual reading at $314.3 million for FY2025, 86.11% up from the prior year.
  • Other Non-Current Liabilities came in at $5.7 million for Q1 2026, down from $314.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $314.3 million in Q4 2025 to a low of $5.6 million in Q2 2025.
  • The 5-year median for Other Non-Current Liabilities is $60.5 million (2022), against an average of $76.7 million.
  • Year-over-year, Other Non-Current Liabilities skyrocketed 1043.24% in 2023 and then crashed 96.96% in 2026.
  • Insmed's Other Non-Current Liabilities stood at $7.4 million in 2022, then surged by 1043.24% to $84.6 million in 2023, then surged by 99.65% to $168.9 million in 2024, then soared by 86.11% to $314.3 million in 2025, then plummeted by 98.19% to $5.7 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Other Non-Current Liabilities are $5.7 million (Q1 2026), $314.3 million (Q4 2025), and $5.6 million (Q3 2025).